HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao Fang Selected Research

1-phenyl-3,3-dimethyltriazene (PDT)

11/2021Nanobiotechnology-enabled energy utilization elevation for augmenting minimally-invasive and noninvasive oncology thermal ablation.
1/2021Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy.
1/2021Mitochondria-Targeted Nanocarriers Promote Highly Efficient Cancer Therapy: A Review.
1/2020ZnS@ZIF-8 core-shell nanoparticles incorporated with ICG and TPZ to enable H2S-amplified synergistic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao Fang Research Topics

Disease

70Neoplasms (Cancer)
07/2022 - 01/2006
15Neoplasm Metastasis (Metastasis)
01/2022 - 11/2010
11Thrombosis (Thrombus)
05/2022 - 04/2013
11Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2014
8Infections
10/2021 - 03/2008
7Inflammation (Inflammations)
04/2022 - 08/2011
7Lung Neoplasms (Lung Cancer)
01/2022 - 07/2015
6Breast Neoplasms (Breast Cancer)
01/2022 - 03/2010
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2015
6Hypoxia (Hypoxemia)
12/2021 - 08/2018
5Rectal Neoplasms (Rectal Cancer)
03/2022 - 08/2018
5Carcinogenesis
01/2022 - 05/2016
5Pathologic Constriction (Stenosis)
01/2022 - 10/2019
4Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 02/2011
4Osteoporosis
05/2022 - 01/2020
4Atherosclerosis
05/2022 - 01/2014
4Vascular System Injuries
01/2022 - 10/2016
3Hemorrhage
05/2022 - 11/2010
3Obesity
02/2022 - 09/2005
3Glioma (Gliomas)
02/2022 - 01/2011
3Pain (Aches)
01/2022 - 11/2005
3Colonic Neoplasms (Colon Cancer)
01/2022 - 06/2016
3COVID-19
01/2022 - 01/2020
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 03/2015
3Insulin Resistance
01/2018 - 09/2005
2Bone Fractures (Bone Fracture)
05/2022 - 11/2020
2Disease Progression
05/2022 - 12/2021
2Bone Diseases (Bone Disease)
05/2022 - 01/2020
2Melanoma (Melanoma, Malignant)
03/2022 - 03/2014
2Lung Diseases (Lung Disease)
02/2022 - 07/2015
2Wounds and Injuries (Trauma)
01/2022 - 01/2018
2Rupture
01/2022 - 10/2019
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2018
2Acute Coronary Syndrome
01/2022 - 05/2014
2Pneumonia (Pneumonitis)
01/2022 - 06/2019
2Circulating Neoplastic Cells
01/2022 - 11/2016
2Atherosclerotic Plaque (Atheroma)
01/2022 - 10/2019
2Anastomotic Leak
10/2021 - 01/2021
2Hemolysis
08/2021 - 01/2011
2Myocardial Infarction
02/2021 - 05/2014
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2009
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2018

Drug/Important Bio-Agent (IBA)

25Pharmaceutical PreparationsIBA
04/2022 - 03/2008
17Proteins (Proteins, Gene)FDA Link
12/2022 - 12/2007
11Biomarkers (Surrogate Marker)IBA
02/2021 - 07/2015
9LipidsIBA
01/2022 - 09/2005
8PlatinumIBA
09/2020 - 07/2015
6Biological ProductsIBA
12/2022 - 12/2016
6MicroRNAs (MicroRNA)IBA
01/2021 - 01/2016
6Angiogenesis InhibitorsIBA
01/2016 - 03/2010
6Peptides (Polypeptides)IBA
08/2015 - 12/2007
5LigandsIBA
01/2022 - 03/2010
5Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 06/2019
5Glucose (Dextrose)FDA LinkGeneric
09/2020 - 09/2005
5Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 03/2010
4CollagenIBA
04/2022 - 01/2015
4Liposomes (Liposome)IBA
03/2022 - 09/2006
41-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 01/2020
4Small Interfering RNA (siRNA)IBA
12/2020 - 09/2017
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 12/2008
3FibrinIBA
05/2022 - 10/2016
3AcidsIBA
03/2022 - 08/2010
3Messenger RNA (mRNA)IBA
01/2022 - 08/2011
3Cisplatin (Platino)FDA LinkGeneric
11/2021 - 02/2011
3CalciumIBA
10/2021 - 05/2014
3ferroceneIBA
10/2021 - 05/2020
3TriterpenesIBA
01/2021 - 02/2013
3Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2020 - 04/2013
3Indicators and Reagents (Reagents)IBA
01/2019 - 08/2010
2discoidin-binding polysaccharideIBA
07/2022 - 05/2021
2PolymersIBA
04/2022 - 10/2021
2ProdrugsIBA
04/2022 - 08/2018
2Matrix Metalloproteinases (MMPs)IBA
04/2022 - 01/2019
2Therapeutic UsesIBA
03/2022 - 03/2019
2EnzymesIBA
03/2022 - 01/2019
2Silicon Dioxide (Silica)FDA LinkGeneric
01/2022 - 12/2020
2Complement System Proteins (Complement)IBA
01/2022 - 07/2017
2MetalsIBA
01/2022 - 01/2021
2Penicillins (Penicillin)FDA Link
01/2022 - 06/2019
2IonsIBA
01/2022 - 10/2021
2Long Noncoding RNAIBA
01/2022 - 06/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2020
2CholesterolIBA
01/2022 - 10/2019
2Phenobarbital (Luminal)FDA Link
01/2022 - 01/2022
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 03/2010
2LactamsIBA
01/2021 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2017
2MacrolidesIBA
01/2021 - 01/2021
2SaponinsIBA
01/2021 - 01/2015
2Oxygen (Dioxygen)IBA
01/2021 - 09/2020
2hydroxide ionIBA
01/2021 - 01/2020

Therapy/Procedure

42Therapeutics
05/2022 - 04/2009
19Drug Therapy (Chemotherapy)
03/2022 - 03/2010
6Immunotherapy
02/2022 - 03/2008
4Lasers (Laser)
05/2022 - 10/2016
4Photochemotherapy (Photodynamic Therapy)
11/2021 - 08/2018
3Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 01/2020
3Radiotherapy
03/2022 - 08/2018
2Neoadjuvant Therapy
03/2022 - 03/2019
2Photothermal Therapy
06/2021 - 05/2020